Objectives Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat
cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We …

Background and Purpose: Stroke is reported as a consequence of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection in several reports. However, data are …

Direct oral anticoagulants (DOACs) are currently the preferred oral anticoagulant treatment
for most of the patients with deep vein thrombosis of the lower extremities and/or pulmonary …

Introduction: Cerebral venous thrombosis (CVT) is a rare disease with highly variable
clinical presentation and outcome. Etiological assessment may be negative. The clinical and …

Background: To describe the outcome of the patients with cerebral venous sinus thrombosis
(CVST) during pregnancy and postpartum treated with anticoagulant therapy. Methods: This …

Thieme E-Journals - Hämostaseologie / Full Text DE EN Home Products Journals Books Book
Series Service Library Service Help Contact Portal Hämostaseologie Full-text search Full-text …

Objective: Unusual clinical course Background: Varicella zoster virus (VZV) infection causes
2 clinically distinct forms of the disease: varicella (chickenpox) and herpes zoster (shingles) …

Background Cerebral venous sinus thrombosis (CVST) is a rare cerebrovascular disorder.
The majority of these patients respond favorably to systemic anticoagulation. However, a …

Cerebral venous sinus thrombosis (CVST) is a rare cause of stroke that accounts for 0.5–
1.0% of all strokes. Clinical presentation, predisposing factors, neuroimaging findings, and …

Background and Purpose: Cerebral vein thrombosis (CVT) incidence is estimated to be> 10
per 1 000 000 per year. Few population-based studies investigating case-fatality rates …